BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2102308)

  • 1. Role of radiation therapy in ovarian cancer.
    Moore DH
    Curr Opin Obstet Gynecol; 1990 Feb; 2(1):64-8. PubMed ID: 2102308
    [No Abstract]   [Full Text] [Related]  

  • 2. The current role of radiotherapy in the management of ovarian cancer.
    Mychalczak BR; Fuks Z
    Hematol Oncol Clin North Am; 1992 Aug; 6(4):895-913. PubMed ID: 1500392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of bevacizumab in ovarian cancer--an evolving story.
    Aghajanian C
    Gynecol Oncol; 2006 Aug; 102(2):131-3. PubMed ID: 16846774
    [No Abstract]   [Full Text] [Related]  

  • 4. Radiolabeled monoclonal antibodies for the diagnosis and treatment of ovarian carcinoma.
    Wahl RL
    Front Radiat Ther Oncol; 1990; 24():228-39. PubMed ID: 2187760
    [No Abstract]   [Full Text] [Related]  

  • 5. Tolerance of moving strip treatment after surgery and chemotherapy in the treatment of ovarian cancer, III stage (F.I.G.O.).
    Micheletti E; Muto P
    Rays; 1985; 10(3):141-6. PubMed ID: 3843663
    [No Abstract]   [Full Text] [Related]  

  • 6. The emerging role of monoclonal antibodies in the clinical management of epithelial ovarian carcinoma.
    Bast RC; Knapp RC
    Important Adv Oncol; 1987; ():39-53. PubMed ID: 3331386
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy.
    Kosmas C; Snook D; Gooden CS; Courtenay-Luck NS; McCall MJ; Meares CF; Epenetos AA
    Cancer Res; 1992 Feb; 52(4):904-11. PubMed ID: 1737353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian carcinoma therapy with monoclonal antibodies.
    Canevari S; Miotti S; Bottero F; Valota O; Colnaghi MI
    Hybridoma; 1993 Oct; 12(5):501-7. PubMed ID: 8300122
    [No Abstract]   [Full Text] [Related]  

  • 9. Radioimmunotherapy of ovarian cancer with radiolabelled monoclonal antibodies: biological basis, present status and future perspectives.
    Bombardieri E; Ferrari L; Spinelli A; Maffioli L; Seregni E; Buraggi G
    Anticancer Res; 1997; 17(3B):1719-29. PubMed ID: 9179225
    [No Abstract]   [Full Text] [Related]  

  • 10. Technical advances in radiation therapy.
    Sause WT
    Urol Clin North Am; 1986 Aug; 13(3):501-23. PubMed ID: 3523928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
    Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ
    Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adjuvant radioactive gold therapy of primary stage I c ovarian cancer].
    Schwarz R; Schumacher A
    Zentralbl Gynakol; 1989; 111(23):1538-41. PubMed ID: 2560301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Radiation therapy effects in ovarian cancer--review].
    Ito H; Uno T; Kawata T; Isobe K
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():560-4. PubMed ID: 15535308
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunotherapy for ovarian cancer.
    Bookman MA
    Curr Opin Oncol; 1990 Oct; 2(5):893-900. PubMed ID: 2095893
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical trials available using radiolabeled MoAbs against colon cancer, lung cancer, ovarian cancer, and hepatic metastases.
    Oncology (Williston Park); 1990 Aug; 4(8):100-1. PubMed ID: 2145005
    [No Abstract]   [Full Text] [Related]  

  • 16. Radiation therapy for gynecologic malignancies.
    Bradley KA; Petereit DG
    Hematol Oncol Clin North Am; 2006 Apr; 20(2):347-61. PubMed ID: 16730298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of radiolabelled monoclonal antibodies to human milk fat globule membrane antigens in antibody-guided tumour imaging, and administration of therapeutic dose of labelled antibody in wide-spread ovarian carcinoma. A preliminary report.
    Ashorn R; Ashorn P; Punnonen R; Pöyhönen L; Turjanmaa V; Koskinen M; Helle M; Uusitalo A; Pystynen P; Krohn K
    Ann Chir Gynaecol Suppl; 1985; 197():5-10. PubMed ID: 3863532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials of targeted alpha therapy for cancer.
    Allen BJ
    Rev Recent Clin Trials; 2008 Sep; 3(3):185-91. PubMed ID: 18782076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of radiation therapy for superficial esophageal cancer using the standard radiotherapy method recommended by the Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group.
    Nemoto K; Yamada S; Nishio M; Aoki M; Nakamura R; Matsumoto Y; Sasamoto R; Saitoh Y; Takayama M; Mitsuhashi N; Gomi K; Kanesaka N; Kobayashi M; Ohnishi H; Sasaki S; Tamamura H; Mitsumori M; Nishimura Y; Tsujino K; Takemoto M; Uchida N; Yamamoto M; Shioyama Y; Hirakawa K; Ono S;
    Anticancer Res; 2006; 26(2B):1507-12. PubMed ID: 16619565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody imaging of colorectal and ovarian cancer.
    Haseman MK
    West J Med; 1994 Oct; 161(4):412. PubMed ID: 7817555
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.